Cell based therapies in Parkinson's Disease
Madhuri Behari1, Kapil Kumar Singhal1
1Department of Neurology, All India Institute of Medical Sciences, New Delhi 110057, INDIA.
Annals of Neurosciences
|September 11, 2014
Summary
Parkinson's disease (PD) is a common neurodegenerative disorder affecting motor function due to dopamine loss. Current treatments focus on dopamine replacement and symptom management, with emerging cell-based therapies on the horizon.
Area of Science:
- Neuroscience
- Neurology
Background:
- Parkinson's disease (PD) is the second leading neurodegenerative disorder, following Alzheimer's disease.
- It is defined by motor symptoms like bradykinesia, rigidity, tremor, and postural instability, stemming from dopaminergic (DA) striatal denervation.
- PD prevalence escalates significantly after age 50, particularly after 60.
Purpose of the Study:
- To review current pharmacological treatments for Parkinson's disease.
- To highlight the role of dopamine replacement therapies.
- To introduce emerging cell-based therapeutic strategies for PD.
Main Methods:
- Literature review of current Parkinson's disease treatments.
- Analysis of pharmacological interventions including L-dopa, dopamine agonists, COMT inhibitors, and MAO-B inhibitors.
- Exploration of novel cell-based therapeutic approaches.
Main Results:
- Levodopa (L-dopa) remains the gold standard treatment for Parkinson's disease.
- Dopamine agonists and inhibitors of COMT and MAO-B are valuable adjunct therapies.
- Cell-based therapeutics represent a promising area for future PD treatment.
Conclusions:
- Current Parkinson's disease management primarily involves dopamine replacement and symptomatic relief.
- A range of pharmacological options exist, with L-dopa being central.
- Cell-based therapies offer a new frontier for treating Parkinson's disease.
Related Concept Videos
01:24Parkinson's Disease: Treatment
1.4K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.4K
01:21EPS and iPS Cells in Disease Research
3.2K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.2K
01:15Parkinson's Disease: Overview
2.2K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.2K
01:24Parkinson Disease ll: Pathophysiology
16
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
16
01:22iPS Cell Differentiation
2.2K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.2K
01:24Parkinson Disease l: Introduction
12
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of...
12